This is a community-generated profile. If you would like to claim it, please .
Contrafect Funding
$43M
55 rounds
Contrafect is active in the following markets / industries: biotechnology. The company has secured funding across 5 rounds, totaling in an amount of $43M. Their most recent funding was raised on September 4, 2013.
Funding Rounds
U
$12000000U
$12500000UnknownSep 2011
A
$2200000B
$12000000U
$4300000Investors of Contrafect
Joel Stahl
I began my career as a customer support rep at fintech exchange ICE. Since 2017, I have been involved in crypto. I can articulate all things related to: the crypto ecosystem, coins, alts, transfers, defi and NFTs. I have expertise in communications.
Caleb Fritz
VC/PE/FinTech
CEO Pacylex, former CEO Sonescence & SEA Medical, CBO Corium, Therashock & StrataGent, VP Auspex, SciDose, Sr. Exec. Nektar, Ligand, Somatogen, PhD U. Wisconsin
Ernie Moody
Video Poker game inventor
Founder of @Granite Loan Management. Investor in @Galvanize Ventures, @Splick–it, @Plink, @ST. Renatus, LLC, @First American State Bank.
Maxim Group
Rounds
U